Ponesimod for treating relapsing multiple sclerosis [ID1393]
In development [GID-TA10556] Expected publication date: 17 November 2021
In development [GID-TA10556] Expected publication date: 17 November 2021
In development [GID-TAG337] Expected publication date: TBC